Frontier IP's inSignals awarded grant for Parkinson's tech.
Frontier IP said on Monday that its portfolio company inSignals Neurotech had been awarded a €317,762 grant, co-financed by the EU under Portugal 2030 through the NORTE 2030 programme, to expand its Parkinson’s monitoring technology to third-party wearables including smartwatches and smart rings. Frontier IP holds a 32.9% equity stake in the company.
Frontier IP Group
06 July 2026 15:11:38
Source: Sharecast
It said InSignals is also launching a mobile app for Parkinson’s patients and caregivers, funded by a previous PRR Green Vouchers grant, to support symptom monitoring and communication with clinicians.
Co-founder and chief scientific officer João Paulo Cunha said the funding would bring its algorithms “beyond specialised clinical settings and into everyday wearable devices”, while Frontier IP chief executive Neil Crabb said the grant and app launch “validate the ground-breaking nature of the Company's technology.”
At 1446 BST, shares in Frontier IP Group were up 15.02% at 16.1p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
N/A
ISIN:
N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes
Compare our accounts
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
